New analysis finds belimumab improves cutaneous lupus erythematosus in patients with or without SLE
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found that the B-cell inhibitor belimumab significantly improved cutaneous lupus erythematosus (CLE) whether ...
Nov 8, 2022
0
0